PD-1 on Immature and PD-1 Ligands on Migratory Human Langerhans Cells Regulate Antigen-Presenting Cell Activity
Open Access
- 1 September 2010
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 130 (9), 2222-2230
- https://doi.org/10.1038/jid.2010.127
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responsesEuropean Journal of Immunology, 2003
- PD-1 Inhibits Antiviral Immunity at the Effector Phase in the LiverThe Journal of Experimental Medicine, 2003
- The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) MiceThe Journal of Experimental Medicine, 2003
- Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 2003
- Tolerogenic Dendritic CellsAnnual Review of Immunology, 2003
- Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine ProductionThe Journal of Immunology, 2003
- Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell ToleranceThe Journal of Experimental Medicine, 2002
- Expression of Programmed Death 1 Ligands by Murine T Cells and APCPublished by The American Association of Immunologists ,2002
- Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissuesImmunology Letters, 2002
- LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell ResponseThe Journal of Immunology, 2000